SIMCERE PHARMACEUTICAL GROUP Noncontrolling Interest, Increase from Business Combination
SIMCERE PHARMACEUTICAL GROUP reported Noncontrolling Interest, Increase from Business Combination of CNY 182.34 million for the 12-month period ending 2009-12-31, per its 20-F filed 2012-04-25.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination · last filed 2012-04-25
| Period end | Noncontrolling Interest, Increase from Business Combination 12 month |
|---|---|
| 2009-12-31 | 182.34M CNY 20-F · filed 2012-04-25 |